California State Teachers Retirement System (CalSTRS)
PLX icon

California State Teachers Retirement System (CalSTRS)’s Protalix BioTherapeutics PLX Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio PLX Stock Details PLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.48K Sell
3,909
-534
-12% -$1.32K ﹤0.01% 2745
2025
Q4 		$8K Buy
4,443
+90
+2% +$184 ﹤0.01% 2859
2025
Q3 		$9.66K Buy
4,353
+3
+0.1% +$5 ﹤0.01% 2841
2025
Q2 		$6.44K Buy
+4,350
New +$8.9K ﹤0.01% 2867
2024
Q2 		– Sell
-6,797
Closed -$8.56K – 3164
2024
Q1 		$8.56K Sell
6,797
-4,122
-38% -$6.15K ﹤0.01% 2937
2023
Q4 		$19.4K Sell
10,919
-3,719
-25% -$5.78K ﹤0.01% 2908
2023
Q3 		$24.3K Sell
14,638
-4,046
-22% -$7.26K ﹤0.01% 2947
2023
Q2 		$37.4K Buy
+18,684
New +$44.5K ﹤0.01% 3003

Other funds holding PLX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s PLX Position: Q1 2026 in Review

California State Teachers Retirement System (CalSTRS) reduced its Protalix BioTherapeutics (PLX) stake by 12% in Q1 2026, selling an estimated $1.32K and leaving 3,909 shares worth $8.48K. The position accounts for ﹤0.01% of the portfolio, ranked #2745.

California State Teachers Retirement System (CalSTRS) first reported a position in PLX in Q2 2023 and has held it in 8 quarters since. The position peaked at $37.4K in Q2 2023. 99 funds tracked by Wall St. Rank hold PLX as of Q1 2026.

  • California State Teachers Retirement System (CalSTRS) held 3,909 shares of Protalix BioTherapeutics worth $8.48K as of Q1 2026.
  • California State Teachers Retirement System (CalSTRS) sold 534 Protalix BioTherapeutics shares in Q1 2026, an estimated $1.32K.
  • Protalix BioTherapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q1 2026, its #2745 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Protalix BioTherapeutics in Q2 2023 and has held it in 8 quarters since.
  • California State Teachers Retirement System (CalSTRS)'s Protalix BioTherapeutics position peaked at $37.4K in Q2 2023.
  • 99 funds tracked by Wall St. Rank held Protalix BioTherapeutics as of Q1 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.